FMR LLC

Position in CAPR — Capricor Therapeutics, Inc.

CIK 315066 BOSTON, MA

Position in CAPR

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$27,396,537

+$3,908,009 QoQ

Shares Held

1,137,730

+47.3% QoQ

Ownership

1.96%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#10

of 169 holders

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,424,667,384 across 370 Biotechnology names. CAPR ranks #134 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	5,231,452	$4,853,584,218
2	ALNY	Alnylam Pharmaceuticals, Inc.	15,023,962	$4,522,663,276
3	MRNA	Moderna, Inc.	51,859,891	$3,631,748,165
4	ROIV	Roivant Sciences Ltd.	81,020,390	$2,867,311,601
5	RVMD	Revolution Medicines, Inc.	12,200,422	$2,284,895,029
6	IONS	Ionis Pharmaceuticals Inc	24,631,956	$1,953,067,789
7	INSM	INSMED Inc	16,143,583	$1,721,228,815
8	KRYS	Krystal Biotech, Inc.	4,418,197	$1,642,111,277

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$27,396,537	1,137,730	+47.3%	Shares	Defined	2026-08-13
2026-03-31	$23,488,528	772,649	-16.3%	Shares	Defined	2026-05-15
2025-12-31	$26,627,215	922,634	+3794.6%	Shares	Defined	2026-02-17
2025-09-30	$170,804	23,690	-2.1%	Shares	Defined	2025-11-13
2025-06-30	$240,205	24,190	-2.3%	Shares	Defined	2025-08-14
2025-03-31	$234,934	24,756	+4.0%	Shares	Defined	2025-05-12
2024-12-31	$328,536	23,807	-2.2%	Shares	Defined	2025-02-13
2024-09-30	$370,272	24,344	+2434300.0%	Shares	Defined	2024-11-13
2024-03-31	$6	1	-97.5%	Shares	Defined	2024-05-13
2021-06-30	$205	40	-82.2%	Shares	Defined	2021-08-13
2021-03-31	$1,053	225	—	Shares	Defined	2021-05-14
No filing history on record for this holder in this stock.